[1,2-a]

[1,2-b]

[1,2-c]

[1,2-d]

[1,2-f]

[1,2-x]

[1,5-a]

[1,5-b]

[1,5-c]

[1,5-d]

[1,6-ad][1,7-a]

[2,1-a]

[2,1-b]

[2,1-c]

[2,1-d]

[2,1-e]

[2,1-f]

[2,1-]

[2,3-a]

[2,3-b]

[2,3-c]

[2,3-d]

[2,3-e]

[2,3-f]

[2,3-g]

[2,3-h]

[2,3-ij][2,4-b]

[3,2-a]

[3,2-b]

[3,2-c]

[3,2-d]

[3,2-e]

[3,2-g]

[3,2-f]

[3,2-h]

[3,4-a]

[3,4-b]

[3,4-c]

[3,4-d]

[3,4-e]

[3,4-f]

[3,4-g]

[3,4-]

[4,3-a]

[4,3-b]

[4,3-c]

[4,3-d]

[4,3-e]

[4,3-g]

[4,3-]

[4,5-a]

[4,5-b]

[4,5-c]

[4,5-d]

[4,5-e]

[4,5-f]

[4,5-g]

[4,5-h]

[4,5-]

[5,1-a]

[5,1-b]

[5,1-c]

[5,1-f]

[5,1-]

[5,4-b]

[5,4-c]

[5,4-d]

[5,4-e]

[5,4-f]

[5,4-]

[5,6-b]

[5,6-c]

[5,6-]

[6,1-b]

[6,1-]

[6,5-b]

[6,5-]

Order 1421372-94-2 N-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMine

Order 1421372-66-8 AZD9291DA HCl salt

Order 1421372-67-9 1,4-BenzenediaMine,?N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]-2-nitro-

Order 1421373-65-0 AZD-9291

Order 13463-28-0 ERIOCITRIN

Order 13463-43-9 Ferrous sulfate monohydrate

Order 134637-67-5 1,3-DIBENZYLOXY-4,6-DINITROBENZENE

Order 142136-39-8 FULLERENE-C76, 98%

Order 1421373-36-5 3-chloro-N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)propanamide

Order 1421373-62-7 Mutant EGFR inhibitor

Order 14214-31-4 2-chloro-3-isothiocyanato-prop-1-ene

Order 58110-37-5 3-(5-(4-CHLOROPHENYL)FURAN-2-YL)ACRYLIC&

Order 53460-78-9 AcetaMide, N-[2-(acetyloxy)-3-chloropropyl]-

Order 534-61-2 [1S-(1alpha,3beta,4beta,5alpha)]-3-[[3-(3,4-dihydroxyphenyl)-1-oxoallyl]oxy]-1,4,5-trihydroxycyclohexanecarboxylic acid

Order 53461-72-6 ETHYL 3-IMINO-3-PHENOXYPROPANOATE HYDROCHLORIDE

Order 1214791-57-7 (2E)-3-(3-Bromo-2-fluorophenyl)prop-2-enoic acid

Order 1246857-70-4 NA

Order 124686-47-1 (4S,5S)-(+)-2,2-DIMETHYL-5-METHYLAMINO-4-PHENYL-1,3-DIOXANE

Order 124689-91-4 N-(L-LEUCYL)-2-AMINOACRIDONE

Order 1246912-83-3 Chlorprothixene-D6